Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01167 JACOBIO-B
RT Nominal unchange1.770 0.000 (0.000%)
Shareholder's Disclosure of Interests
Disclosure of Interest   ｜   Fund Raising   ｜   Share Repurchase
Date Shareholder name Reason of Disclosure Buy/Sell and
Involved Shares		 Average Price per share Current Holdings % of Issued Shares
07/10/2024Wang Xiaojie1112(L)+2,400(L)HKD2.410(L)211,154,150(L)26.67
07/10/2024Hu Yunyan1112(L)+2,400(L)HKD2.410(L)211,154,150(L)26.67
07/10/2024Wang Yinxiang1112(L)+2,400(L)HKD2.410(L)211,154,150(L)26.67
04/09/2024Vistra Trust (Singapore) Pte. Limited1704(L)-211,151,750(L)0(L)0.00
04/09/2024Vistra Trust (Singapore) Pte. Limited1704(L)-211,151,750(L)0(L)0.00
04/09/2024Silver Summit Group Limited1704(L)-211,151,750(L)0(L)0.00
04/09/2024Wang Xiaojie1316(L)22,932,500(L)211,151,750(L)26.67
04/09/2024Easy Sonic International Limited1704(L)-211,151,750(L)0(L)0.00
04/09/2024Hu Yunyan1316(L)23,081,095(L)211,151,750(L)26.67
19/06/2024Hillhouse Investment Management, Ltd.1113(L)47,443,510(L)6.00
19/06/2024HH SPR-III Holdings Limited1113(L)47,443,510(L)6.00
19/06/2024Hillhouse Fund IV, L.P.1113(L)47,443,510(L)6.00
26/01/2024Hmed Ltd1211(L)211,151,750(L)26.67
26/01/2024Wang Yinxiang1211(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Honourpharma Ltd1211(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Blesspharma Ltd1211(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Yakovpharma Ltd1211(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Hu Yunyan1211(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Shen Zhu1213(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Johwpharma Ltd1211(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Wang Xiaojie1202(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Willgenpharma Ltd1211(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024ULTIMATE ESTATE LIMITED1213(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Risepharma Ltd1202(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024Gloryviewpharma Ltd1211(L)-10,000,000(L)211,151,750(L)26.67
26/01/2024TREASURE PARTNER INTERNATIONAL LIMITED1211(L)-10,000,000(L)211,151,750(L)26.67
29/12/2023Hillhouse Fund IV, L.P.1201(L)-99,900(L)HKD3.381(L)47,443,510(L)5.99
29/12/2023Hillhouse Investment Management, Ltd.1201(L)-99,900(L)HKD3.381(L)47,443,510(L)5.99
29/12/2023HH SPR-III Holdings Limited1201(L)-99,900(L)HKD3.381(L)47,443,510(L)5.99
05/10/2023Hu Yunyan1112(L)+33,600(L)HKD2.940(L)221,151,750(L)27.87
05/10/2023Wang Xiaojie1112(L)+33,600(L)HKD2.940(L)221,151,750(L)27.87
05/10/2023Wang Yinxiang1112(L)+33,600(L)HKD2.940(L)221,151,750(L)27.87
04/10/2023Wang Xiaojie1112(L)+198,300(L)HKD2.996(L)221,118,150(L)27.86
04/10/2023Wang Yinxiang1112(L)+198,300(L)HKD2.996(L)221,118,150(L)27.86
04/10/2023Hu Yunyan1112(L)+198,300(L)HKD2.996(L)221,118,150(L)27.86
03/10/2023Hu Yunyan1112(L)+57,300(L)HKD2.975(L)220,919,850(L)27.84
03/10/2023Wang Yinxiang1112(L)+57,300(L)HKD2.975(L)220,919,850(L)27.84
03/10/2023Wang Xiaojie1112(L)+57,300(L)HKD2.975(L)220,919,850(L)27.84
29/09/2023Wang Xiaojie1112(L)+95,700(L)HKD3.048(L)220,862,550(L)27.83
29/09/2023Hu Yunyan1112(L)+95,700(L)HKD3.048(L)220,862,550(L)27.83
 1   2   3  
Remark: (L) - Long Position, (S) - Short Position, (P) Lending;
  Real time quote last updated: 11/11/2024 13:19
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.